Impact of appropriate empirical antibiotics on clinical outcomes in Klebsiella pneumoniae bacteraemia

被引:3
|
作者
Man, M. Y. [1 ]
Shum, H. P. [1 ]
Li, K. C. [1 ]
Yan, W. W. [1 ]
机构
[1] Pamela Youde Nethersole Eastern Hosp, Dept Intens Care, Hong Kong, Peoples R China
关键词
ANTIMICROBIAL THERAPY; SOFA SCORE; SEPSIS; RESISTANCE; MORTALITY; CARE;
D O I
10.12809/hkmj208698
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Klebsiella pneumoniae infections can cause septic shock, multiorgan failure, and death. Methods: This retrospective cohort study included adults with K pneumoniae bacteraemia treated from 1 January 2009 to 30 June 2017. Demographics, microbiology, and outcomes were analysed. The primary outcome was 90-day all-cause mortality; secondary outcomes were intensive care unit (ICU) and hospital mortalities, ICU and hospital lengths of stay, and ICU ventilator duration. Results: In total, 984 patients had K pneumoniae bacteraemia; of them, 686 received appropriate empirical antibiotics. Overall, 205 patients required intensive care. Older age (odds ratio [OR]=1.60; 95% confidence interval [CI]=1.120-2.295; P=0.010), chronic kidney disease (OR=1.81; 95% CI=1.181-2.785; P=0.007), mechanical ventilation (OR=1.79; 95% CI=1.188-2.681; P=0.005), pneumonia (OR=1.50; 95% CI=1.030-2.187; P=0.034), and carbapenem-resistant or extended-spectrum beta-lactamase (ESBL)-producing isolates (OR=12.51; 95% CI=7.886-19.487; P<0.001) were associated with greater risk of inappropriate empirical treatment. Ninety-day mortality was significantly higher among patients with inappropriate empirical treatment; independent predictors included pneumonia (hazard ratio [HR]=2.94; 95% CI=2.271-3.808; P<0.001), gastrointestinal infection (HR=2.77; 95% CI=2.055-3.744; P<0.001), failed empirical antibiotics (HR=2.45; 95% CI=1.928-3.124; P<0.001), older age (HR=1.79; 95% CI=1.356-2.371; P<0.001), solid tumour (HR=1.77; 95% CI=1.401-2.231; P<0.001), carbapenem-resistant or ESBL-producing isolates (HR=1.64; 95% CI=1.170-2.297; P=0.004), patients admitted through the Department of Medicine (HR=1.39; 95% CI=1.076-1.800; P=0.012), and higher total Sequential Organ Failure Assessment score (HR=1.09; 95% CI=1.058-1.112; P=0.023). Among ICU patients, inappropriate empirical antibiotic treatment was significantly associated with increased ventilator duration and 90-day mortality. Conclusions: Klebsiella pneumoniae bacteraemia was associated with high 90-day and ICU mortalities; 90-day mortality increased with inappropriate empirical antibiotic treatment.
引用
收藏
页码:247 / 257
页数:11
相关论文
共 50 条
  • [31] Impact of revised susceptibility breakpoints on bacteremia of Klebsiella pneumoniae: Minimum inhibitory concentration of cefazolin and clinical outcomes
    Chuang, Chia-Hui
    Liu, Meei-Fang
    Lin, Chin-Fu
    Shi, Zhi-Yuan
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2016, 49 (05) : 679 - 684
  • [33] Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections
    Ny, Pamela
    Nieberg, Paul
    Wong-Beringer, Annie
    AMERICAN JOURNAL OF INFECTION CONTROL, 2015, 43 (10) : 1076 - 1080
  • [34] Mortality due to blaKPC Klebsiella pneumoniae bacteraemia-authors' response
    Wiener-Well, Yonit
    Raveh-Brawer, David
    Fraenkel-Wandel, Yedidah
    Yinnon, Amos M.
    Assous, Marc V.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (06) : 1744 - +
  • [35] Potential for Cefazolin as De-escalation Therapy for Klebsiella Pneumoniae Bacteraemia
    Ng, Tat Ming
    Teng, Christine B.
    Lew, Ee Ling
    Ling, Li Min
    Ang, Brenda
    Lye, David C.
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2015, 44 (12) : 571 - 574
  • [36] Impact of appropriate empirical antibiotic treatment on recurrence and mortality in patients with bacteraemia: a populationbased cohort study
    Gradel, Kim O.
    Jensen, Ulrich S.
    Schonheyder, Henrik C.
    Ostergaard, Christian
    Knudsen, Jenny D.
    Wehberg, Sonja
    Sogaard, Mette
    BMC INFECTIOUS DISEASES, 2017, 17
  • [37] Clinical epidemiology and outcomes of biliary tract infections caused by Klebsiella pneumoniae
    Li, Lanyu
    Zhu, Changqing
    Huang, Huan
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (14)
  • [38] Hypervirulent Klebsiella pneumoniae have better clinical outcomes than classical Klebsiella pneumoniae for lower respiratory tract infection patients
    Xianxia Zhuo
    Zichen Lei
    Danni Pu
    Yongli Wu
    Jiankang Zhao
    Bin Cao
    BMC Microbiology, 25 (1)
  • [39] Susceptibility of Klebsiella pneumoniae clinical isolates from 2007 to 2009 to colistin and comparator antibiotics
    Hawser, Stephen P.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 (04) : 383 - 384
  • [40] Quantifying the clinical virulence of Klebsiella pneumoniae producing carbapenemase Klebsiella pneumoniae with a Galleria mellonellamodel and a pilot study to translate to patient outcomes
    Milena M McLaughlin
    M Renee Advincula
    Michael Malczynski
    Grace Barajas
    Chao Qi
    Marc H Scheetz
    BMC Infectious Diseases, 14